Results 61 to 70 of about 18,707 (219)
Brain and Behavior, 2021 Objective To compare the effectiveness and tolerability of agomelatine with mirtazapine in patients with depressive disorder. To illustrate the prescribing pattern of agomelatine and identify factors that affect the pattern of treatment result and ...
Shek Ming Leung
doaj +1 more source
Perspective: Depression in Persons with Parkinson's Disease
Movement Disorders, EarlyView.Abstract Depression is a prevalent and disabling syndrome characterized by sustained sadness and/or anhedonia, as well as cognitive and physical symptoms. In Parkinson's disease (PD), depression is both common and clinically challenging due to overlapping symptoms and complex etiologic interactions. Major depressive disorder occurs in approximately 17%
Albert F.G. Leentjens +1 more
wiley +1 more source
Anton Valavanis, a Leader in Swiss Neuroscience
Clinical and Translational Neuroscience, 2023 Professor Anton Valavanis [...]
Luca Remonda +4 more
doaj +1 more source
The Stability Region of the Two-User Interference Channel
, 2013 The stable throughput region of the two-user interference channel is investigated here. First, the stability region for the general case is characterized.
Ephremides, Anthony +2 more
core +3 more sources
Otolaryngology–Head and Neck Surgery, EarlyView.Abstract Objective Comorbid depression is a significant negative predictor of survival in patients with head and neck cancer (HNC). Prior studies have shown a prevalence of up to 40.1%; however, depression is often underdiagnosed in this patient population. Study Design Retrospective cohort. Setting Single‐institution database.
Sindhura Sridhar +8 more
wiley +1 more source
Health Science Reports, 2022 Background and Aim Due to the high social and economic burden and also mortality and morbidity caused by coronavirus disease 2019 (COVID‐19) in the past few years, researchers have aimed at finding solutions to suppressing the severity of infection ...
Dena Firouzabadi +4 more
doaj +1 more source
Serotonin Noradrenaline Reuptake Inhibitors (SNRIs) [PDF]
, 2012 Antidepressants that block the reuptake of serotonin (5-HT) and noradrenaline (NA) are called 5-HT and NA reuptake inhibitors (SNRIs). SNRIs are agents that show “dual action” on 5-HT and NA. These drugs bind the 5-HT transporters (SERT) and NA transporters (NAT) similar to tricyclic antidepressants (TCAs). However, SNRIs differ from TCAs in that SNRIs
Ipek Komsuoglu, Oguz Mutlu, Guner Ulak
openaire +1 more source
SSRI and SNRI withdrawal symptoms reported on an internet forum [PDF]
International Journal of Risk & Safety in Medicine, 2018 BACKGROUND: Antidepressant withdrawal symptoms are well-recognised, but their potential duration remains uncertain. OBJECTIVE: We aimed to describe the characteristics of withdrawal associated with two popular classes of antidepressants, including duration.
Stockmann, T +3 more
openaire +3 more sources
BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.ABSTRACT Objective To investigate the factors associated with non‐vasomotor menopause symptoms among women in the UK, focusing on the perceived importance of specific symptoms and their association with demographic and treatment‐related factors. Design A cross‐sectional online survey.
Rhianna Davies +12 more
wiley +1 more source
JA Clinical Reports, 2019 Background Serotonin syndrome is a rare but potentially severe disease, which is caused by hyperstimulation of serotonin receptors in the central nervous system.
Junko Takata +4 more
doaj +1 more source